GSK plc GSK
NYSE GSK
$48.68 -0.08 (-0.16%)
At close: Oct 29, 2026 · 4:00 PM EDT

Gsk (GSK) Non-Current Assets (2009 - 2026)

Updated

Gsk (GSK) posted Non-Current Assets of $71.2 billion for the quarter ended Sep 30, 2026, up 21.8% from $58.45 billion a year earlier and up 21.6% from the prior quarter.

Analysis

Gsk (GSK) Non-Current Assets (2009 - 2026) Analysis & Trends

As of Dec 31, 2025, Gsk's Non-Current Assets came in at $58.73 billion, up 10.2% from the prior year.

  • Annual Non-Current Assets has increased for four consecutive years, though with a five-year compound annual growth rate of -6.5% (years ended Dec 2020 to Dec 2025).
  • In prior years, Gsk's Non-Current Assets was $53.29 billion in the year ended Dec 31, 2024 (+3.7%), $51.4 billion in the year ended Dec 31, 2023 (+8.3%), $47.47 billion in the year ended Dec 31, 2022 (+20.4%) and $39.42 billion in the year ended Dec 31, 2021 (-52.0%).
  • The figure for the quarter ended Sep 30, 2026 stands as the highest quarterly Non-Current Assets since the quarter ended Mar 31, 2022.
  • On a year-over-year basis, Non-Current Assets has increased in each of the last 14 quarters, with growth averaging 8.5% over the last eight quarters.
  • The strongest year-over-year quarter for Non-Current Assets in the past five years was the quarter ended Sep 30, 2026, with growth of 21.8%; the weakest was the quarter ended Jun 30, 2022, with a decline of 48.6%.
  • According to Business Quant data, Non-Current Assets for the three prior quarters was $58.55 billion (quarter ended Jun 30, 2026), $59.42 billion (quarter ended Mar 31, 2026) and $58.73 billion (quarter ended Dec 31, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Eli Lilly 1,264.17 Bn 1,237.79 Bn 20.46 Bn 82.81 Bn
2 Johnson & Johnson 660.04 Bn 579.90 Bn 17.30 Bn 141.07 Bn
3 AbbVie 521.06 Bn 494.17 Bn 12.70 Bn 101.45 Bn
4 Merck 370.60 Bn 370.60 Bn - -
5 Novartis Ag 311.97 Bn 285.20 Bn - -
6 Astrazeneca 288.69 Bn 262.37 Bn 12.86 Bn 87.87 Bn
7 Amgen 252.29 Bn 207.69 Bn 7.24 Bn 60.68 Bn
8 Gilead Sciences 213.47 Bn 213.47 Bn - -
9 Pfizer 173.68 Bn 120.32 Bn 10.94 Bn 159.77 Bn
10 Gsk 100.27 Bn 83.11 Bn 8.73 Bn 71.20 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 71.20 Bn
Jun 30, 2026 58.55 Bn
Mar 31, 2026 59.42 Bn
Dec 31, 2025 58.73 Bn
Sep 30, 2025 58.45 Bn
Jun 30, 2025 57.05 Bn
Mar 31, 2025 55.14 Bn
Dec 31, 2024 53.29 Bn
Sep 30, 2024 54.54 Bn
Jun 30, 2024 52.23 Bn
Mar 31, 2024 52.15 Bn
Dec 31, 2023 51.40 Bn
Sep 30, 2023 48.36 Bn
Jun 30, 2023 50.60 Bn
Mar 31, 2023 48.16 Bn
Dec 31, 2022 47.47 Bn
Sep 30, 2022 44.75 Bn
Jun 30, 2022 42.29 Bn
Mar 31, 2022 79.75 Bn
Dec 31, 2021 81.57 Bn
API Access

Gsk Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=GSK&period=max&api_key=YOUR_API_KEY